Beth Faiman

Featured in: Favicon

wiley.com

mdpi.com

healio.com Favicon

cancernetwork.com Favicon

onclive.com Favicon

oncnursingnews.com Favicon

conquer-magazine.com Favicon

onlinelibrary.wiley.com

Articles

Insights on Evolving Treatment Strategies for Multiple Myeloma

Jun 19, 2024 | oncnursingnews.com | Donna Catamero |Beth Faiman |Tiffany Richards

The panel provides key takeaways on the most impactful innovations shaping the future of multiple myeloma treatment.
Clinical Advice on Caring for Patients Treated With Talquetamab

Jun 19, 2024 | oncnursingnews.com | Donna Catamero |Beth Faiman |Tiffany Richards

Clinical Advice on Caring for Patients Treated With TalquetamabThe panel provides clinical advice on caring for patients with multiple myeloma who are treated with talquetamab.
Integrating GPRC5D-Targeting Bispecifics for Relapsed/Refractory MM

Jun 19, 2024 | oncnursingnews.com | Donna Catamero |Beth Faiman |Tiffany Richards

Beth Faiman, PhD, MSN, explores how a GPRC5D-targeting bispecific antibody can benefit patients with relapsed/refractory multiple myeloma.
Managing Toxicities From Talquetamab in Multiple Myeloma

Jun 19, 2024 | oncnursingnews.com | Donna Catamero |Beth Faiman |Tiffany Richards

Experts explore strategies to effectively manage toxicities associated with talquetamab in the treatment of multiple myeloma.
Strategies for Discussing Potential Adverse Effects of Talquetamab in MM

Jun 19, 2024 | oncnursingnews.com | Donna Catamero |Beth Faiman |Tiffany Richards

Strategies for Discussing Potential Adverse Effects of Talquetamab in MMExperts discuss best practices for educating patients with multiple myeloma on the adverse effects associated with talquetamab treatment.
Navigating MM Treatment: Sequencing Strategies and Integrating Talquetamab

Jun 19, 2024 | oncnursingnews.com | Donna Catamero |Beth Faiman |Tiffany Richards

This session explores clinical evidence for sequencing treatments in MM, highlighting the safety profile of talquetamab as a potential tool in your MM patient management.
Clinical Scenario: Treating Late-Line Relapsed Multiple Myeloma

Jun 19, 2024 | oncnursingnews.com | Donna Catamero |Beth Faiman |Tiffany Richards

Following the repeat diagnostic workup presentation, an expert will lead the discussion, inviting the panel's input on the most appropriate treatment course for this patient.
Empowering Patients With Myeloma Through Resources

Jun 19, 2024 | oncnursingnews.com | Donna Catamero |Beth Faiman |Tiffany Richards

The panel discussed resources to equip nurses in educating patients with multiple myeloma about their treatment options.
Case Study: 63-Year-Old Man With Multiple Myeloma

Jun 19, 2024 | oncnursingnews.com | Donna Catamero |Beth Faiman |Tiffany Richards

A team of multiple myeloma experts review a patient profile, offering preliminary insights and underscoring the importance of advanced practice providers in optimizing patient care.
Evaluating ChatGPT as an educational resource for patients with multiple myeloma: A preliminary investigation

Apr 12, 2024 | onlinelibrary.wiley.com | Ludovic Saba |Chieh-Lin Fu |Jack Khouri |Beth Faiman

Multiple myeloma (MM) is a complex hematological malignancy characterized by malignant plasma cell proliferation usually within the bone marrow.1 Patients diagnosed with MM face multiple challenges, including understanding the intricacies of their condition, available treatment modalities, side effects, supportive care, and the consequent prognostic implications.